Yes, I agree and hope that Cytodyn is treated fairly and based solely on scientific principles. The reason I brought up the 43% tatget from the MESO trial is because Dr. Rahman came from MESO and so I'm sure he was involved in the trial design and target selection. So I'd be curious to know his opinion what would be the approval efficacy criteria.